Skip to main content
SpringerLink
Log in
Book cover

Antiepileptic Drug Interactions pp 87–93Cite as

Oxcarbazepine

  • Chapter
  • First Online:

  • 1456 Accesses

Abstract

Oxcarbazepine (Fig. 1) corresponds chemically to10,11-dihydro-10-oxo-5H-dibenz(b,f)azepine-4-carboxamide with an empirical formula of C15H12N2O2 and a molecular weight of 252.27.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. McKee PJW, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol. 1994;37:27–32.

    Article  PubMed  CAS  Google Scholar 

  2. Arnoldussen W, Hulsman J, Rentmeester T. The interaction of valproate and clobazam on the metabolism of oxcarbazepine. Epilepsia. 1993;34 (Suppl 2):160.

    Google Scholar 

  3. Hulsman JARJ, Rentmeester TW, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Radwanski E, Mojavarian P, Lin CC, Nezamis J, Affrime MB, Glue P. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. Clin Pharmacol Ther. 1995;58:383–9.

    Article  PubMed  CAS  Google Scholar 

  4. Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M, Rosenow F, Doty P, Hebert D, Sullivan T. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia. 2009;50:443–53.

    Article  PubMed  CAS  Google Scholar 

  5. Novy J, Patsalos PN, Sander JW, Sisodiya SM. Lacosamide neurotoxicity associated with concomitant use of sodium-blocking antiepileptic drugs: a pharmacodynamic interaction? Epilepsy Behav. 2011;20:20–3.

    Article  PubMed  Google Scholar 

  6. Armijo JA, Vega-Gil N, Shushtarian M, Adin J, Herranz JL. 10-Hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio. Influence of age and concomitant antiepileptic drugs. Ther Drug Monit. 2005;27:199–204.

    Article  PubMed  CAS  Google Scholar 

  7. Tartara A, Galimberti CA, Manni R, Morino R, Limido G, Gatti G, Bartoli A, Strada G, Perucca E. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbital and valproic acid. Br J Clin Pharmacol. 1993;36:366–8.

    Article  PubMed  CAS  Google Scholar 

  8. May TW, Rambeck B, Salke-Kellermann A. Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients. Acta Neurol Scand. 1996;93:393–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCL-Institute of Neurology Department of Clinical and Experimental Epilepsy, Queen Square, London, London

    P. N. Patsalos

  2. Epilepsy Society Chalfont Centre for Epilepsy, Chalfont St Peter, Buckinghamshire, UK

    P. N. Patsalos

Authors
  1. P. N. Patsalos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Patsalos, P.N. (2013). Oxcarbazepine. In: Antiepileptic Drug Interactions. Springer, London. https://doi.org/10.1007/978-1-4471-2434-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2434-4_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2433-7

  • Online ISBN: 978-1-4471-2434-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation